Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gynecomastia with ketoconazole.

R DeFelice, D G Johnson, J N Galgiani

    Antimicrobial Agents and Chemotherapy
    |June 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Ketoconazole treatment caused bilateral gynecomastia in three men. Symptoms resolved even with ongoing medication, suggesting a direct drug effect on breast tissue.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Contrasting effects of an Mdm2 functional polymorphism on tumor phenotypes.

    Oncogene·2017
    Same author

    Determination of the primary charge separation rate in Photosystem II reaction centers at 15 K.

    Photosynthesis research·2014
    Same author

    Short communication: Jersey × Holstein crossbreds compared with pure Holsteins for body weight, body condition score, fertility, and survival during the first three lactations.

    Journal of dairy science·2012
    Same author

    Short communication: Jersey × Holstein crossbreds compared with pure Holsteins for production, mastitis, and body measurements during the first 3 lactations.

    Journal of dairy science·2010
    Same author

    Implantable micropump technologies for murine intracochlear infusions.

    Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2010
    Same author

    Phase determination from mostly one-sided interferograms.

    Applied optics·2010
    Same journal

    <i>In vitro</i> antibacterial activity of gepotidacin in combination with other antimicrobial agents against <i>Neisseria gonorrhoeae</i> isolates.

    Antimicrobial agents and chemotherapy·2026
    Same journal

    Development of domain-specific probes of <i>Plasmodium falciparum</i> heat shock protein 70-1.

    Antimicrobial agents and chemotherapy·2026
    Same journal

    Addressing therapeutic options for KPC-3-producing ST307-<i>Klebsiella pneumoniae</i>: insights from <i>in vitro</i> evolution and mutant prevention strategies.

    Antimicrobial agents and chemotherapy·2026
    Same journal

    Indole-based hybrids target both asexual parasites and gametocytes of <i>Plasmodium falciparum</i> and synergize with lumefantrine.

    Antimicrobial agents and chemotherapy·2026
    Same journal

    Lineage-specific loss of the type VI secretion system in <i>Acinetobacter baumannii</i> ST19 is associated with reduced accessory genome content.

    Antimicrobial agents and chemotherapy·2026
    Same journal

    Genomic diversity and topical antimicrobial resistance in <i>Staphylococcus aureus</i> from clinical and carriage populations in the New York-New Jersey region.

    Antimicrobial agents and chemotherapy·2026
    See all related articles

    Area of Science:

    • Endocrinology
    • Pharmacology
    • Oncology

    Background:

    • Ketoconazole is a broad-spectrum antifungal agent.
    • Gynecomastia is the enlargement of breast tissue in males.

    Observation:

    • Three out of forty male patients developed bilateral gynecomastia during ketoconazole therapy.
    • The gynecomastia symptoms resolved spontaneously despite continued ketoconazole treatment.

    Findings:

    • The observed gynecomastia appears to be a direct pharmacological effect of ketoconazole on breast tissue.
    • This suggests a potential endocrine-disrupting property of ketoconazole.

    Implications:

    • Clinicians should be aware of the potential for ketoconazole-induced gynecomastia.
    • Further research may be warranted to elucidate the precise mechanism of this adverse effect.